Clinical Trial Update: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus [Phase 2]

View source ↗

Summary

This Phase 2 trial examined biomarkers before and after nephrectomy in patients with locally advanced or metastatic renal cell carcinoma treated with everolimus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Conditions: Clear-cell Renal Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED